• Register
  • Login

European Journal of Molecular & Clinical Medicine

  1. Home
  2. Efficacy and reliability of 0.5% hyperbaric Bupivacaine and 0.75% isobaric Ropivacaine for intra-thecal use in patients undergoing lower abdominal and lower limb surgeries

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

Journal Metrics

News

Efficacy and reliability of 0.5% hyperbaric Bupivacaine and 0.75% isobaric Ropivacaine for intra-thecal use in patients undergoing lower abdominal and lower limb surgeries

    Author

    • Dr. Kalluri Saipriyanka, Dr. Satyanarayana Kuruba Pujari, Dr. Paresh Nagwekar, Dr. Shree Harsha M

    India

,

Document Type : Research Article

  • Article Information
  • Download
  • Export Citation
  • Statistics
  • Share

Abstract

Bupivacaine is three to four times more potent than lignocaine4 and has a longer duration of action. Bupivacaine is an amide group of drug that is most frequently used for spinal anaesthesia. Both hyperbaric and isobaric forms are available. Hyperbaric solutions produce a more predictable extension of sensory block, short duration of block and faster recovery than isobaric solutions. The study was undertaken after obtaining ethical committee clearance as well as informed consent from all the patients. One hundred and twenty six patients in the age group between 20 years and 60 years of either sex belonging to ASA I and II posted for elective lower abdominal surgeries were grouped randomly into two groups (n=63). The mean time taken for attaining the maximum sensory blockade is 8.62±2.08 minutes in Group 1 and in Group 2 it is 8.71±2.59 minutes. Statistically there is no significance between the groups (p>0.05). The mean time taken to achieve maximum motor blockade in Group 1 is 7.03±2.24 minutes and in Group 2 it is 8.56±2.49 minutes, which is statistically significant between the groups (p<0.001).
 

  • XML
  • PDF 172.21 K
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
    • Article View: 39
    • PDF Download: 105
European Journal of Molecular & Clinical Medicine
Volume 9, Issue 4
July 2022
Page 3788-3793
Files
  • XML
  • PDF 172.21 K
Share
Export Citation
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 39
  • PDF Download: 105

APA

Dr. Paresh Nagwekar, Dr. Shree Harsha M, D. K. S. D. S. K. P. (2022). Efficacy and reliability of 0.5% hyperbaric Bupivacaine and 0.75% isobaric Ropivacaine for intra-thecal use in patients undergoing lower abdominal and lower limb surgeries. European Journal of Molecular & Clinical Medicine, 9(4), 3788-3793.

MLA

Dr. Kalluri Saipriyanka, Dr. Satyanarayana Kuruba Pujari, Dr. Paresh Nagwekar, Dr. Shree Harsha M. "Efficacy and reliability of 0.5% hyperbaric Bupivacaine and 0.75% isobaric Ropivacaine for intra-thecal use in patients undergoing lower abdominal and lower limb surgeries". European Journal of Molecular & Clinical Medicine, 9, 4, 2022, 3788-3793.

HARVARD

Dr. Paresh Nagwekar, Dr. Shree Harsha M, D. K. S. D. S. K. P. (2022). 'Efficacy and reliability of 0.5% hyperbaric Bupivacaine and 0.75% isobaric Ropivacaine for intra-thecal use in patients undergoing lower abdominal and lower limb surgeries', European Journal of Molecular & Clinical Medicine, 9(4), pp. 3788-3793.

VANCOUVER

Dr. Paresh Nagwekar, Dr. Shree Harsha M, D. K. S. D. S. K. P. Efficacy and reliability of 0.5% hyperbaric Bupivacaine and 0.75% isobaric Ropivacaine for intra-thecal use in patients undergoing lower abdominal and lower limb surgeries. European Journal of Molecular & Clinical Medicine, 2022; 9(4): 3788-3793.

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

© Journal Management System. Powered by ejournalplus